decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Anti-Kickback Advisory Opinion Summaries / 2004 OIG Advisory Opinions / Opinion 04-17 - Pathology Services Joint Venture Invites Fraud
Subscribe or sign in to view the full article.
Article Overview
This premium summary reviews a 2004 OIG advisory opinion under the Anti-Kickback framework involving a proposed pathology services joint venture. It explains the general arrangement, the OIG’s compliance concerns, and why the proposal was viewed as problematic from an overutilization and referral-risk perspective. The article is intended for readers who follow fraud-and-abuse guidance, physician arrangements, and laboratory or pathology services models.
Why This Topic Matters
This matters because it highlights how the OIG evaluates joint venture structures that may create referral-driven incentives, especially in laboratory and pathology service arrangements. It is relevant to compliance, legal, and revenue-cycle professionals assessing fraud-and-abuse risk in physician-business relationships.
What You Will Learn
- The type of pathology services arrangement reviewed by the OIG
- The general fraud-and-abuse concerns raised by the proposed joint venture
- How referral dependence and ownership structure factor into OIG review
- Why utilization-based payment structures can raise compliance concerns
Who Should Read This
- Compliance officers
- Healthcare attorneys
- Physician practice administrators
- Revenue cycle professionals
- Pathology and laboratory service leaders
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com